First Header Logo Second Header Logo

Connection

David Kline to Myotonia Congenita

Back to Details
This is a "connection" page, showing publications David Kline has written about Myotonia Congenita.
David Kline
Connection Strength
0.149
Myotonia Congenita
  1. Arnold WD, Kline D, Sanderson A, Hawash AA, Bartlett A, Novak KR, Rich MM, Kissel JT. Open-label trial of ranolazine for the treatment of myotonia congenita. Neurology. 2017 Aug 15; 89(7):710-713.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.